NEU1 and Alzheimer disease: Because NEU1 and Trem2 are implicated in neurodegenerative/neuro-inflammatory diseases, including Alzheimer’s disease and sialidosis, modulating NEU1 activity may present a therapeutic approach to broadly regulate microglia-mediated neuroinflammation.